Loading data
FCUVNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 255.02 k USD | 398.14 k USD | 440.54 k USD | 353.62 k USD | 1.43 m USD |
| Cost of revenue | 290.28 k USD | 387.94 k USD | 380.88 k USD | 330.9 k USD | 1.14 m USD |
| Gross profit | -35.25 k USD | 10.2 k USD | 59.66 k USD | 22.72 k USD | 297.16 k USD |
| Research and development expense | 919.97 k USD | 1.38 m USD | 1.32 m USD | 1.06 m USD | 220.47 k USD |
| Operating profit | -4.89 m USD | -6.2 m USD | -4.95 m USD | -5.21 m USD | -3.02 m USD |
| Profit before tax | — | — | — | -4.93 m USD | -3.22 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -4.79 m USD | -3.2 m USD | -4.72 m USD | -4.93 m USD | -3.22 m USD |
| Net income attributable to common shareholders | -5.24 m USD | -3.2 m USD | — | — | — |
| Basic earnings per share | -7.07 USD/share | -4.77 USD/share | -0.78 USD/share | -0.08 USD/share | -0.08 USD/share |
| Diluted earnings per share | -7.07 USD/share | -4.77 USD/share | -0.78 USD/share | -0.08 USD/share | -0.08 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.